66750 Federal Register / Vol. 83, No. 247 / Thursday, December 27, 2018 / Notices 

necessitates that this Order be effective 

immediately. 21 CFR 1316.67. 

Dated: December 11, 2018. 

Uttam Dhillon, 

Acting Administrator. 

[FR Doc. 2018–28072 Filed 12–26–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Johnson Matthey Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before January 28, 2019. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 28, 2019. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 

3417, (January 25, 2007) 

SUPPLEMENTARY INFORMATION: 

The Attorney General has delegated 

his authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on October 

15, 2018, Johnson Matthey Inc., 2003 

Nolte Drive, West Deptford, New Jersey 

08066 applied to be registered as an 

importer of the following basic classes 

of controlled substances: 

Controlled substance Drug code Schedule 

Coca Leaves ............................................................................................................................................................ 9040 II 

Thebaine .................................................................................................................................................................. 9333 II 

Opium, raw .............................................................................................................................................................. 9600 II 

Noroxymorphone ..................................................................................................................................................... 9668 II 

Poppy Straw Concentrate ........................................................................................................................................ 9670 II 

Fentanyl ................................................................................................................................................................... 9801 II 

The company plans to import coca 

leaves (9040), raw opium (9600), and 

poppy straw concentrate (9670) in order 

to bulk manufacture active 

pharmaceutical ingredients (API) for 

distribution to its customers. The 

company plans to also import thebaine 

(9333), noroxymorophone (9668), and 

fentanyl (9801) to use as analytical 

reference standards, both internally and 

to be sold to their customers to support 

testing of Johnson Matthey Inc.’s API’s 

only. 

Dated: December 8, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–28073 Filed 12–26–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Registration 

ACTION: Notice of registration. 

SUMMARY: The registrant listed below 

has applied for and been granted 

registration by the Drug Enforcement 

Administration (DEA) as an importer of 

various classes of schedule I or II 

controlled substances. 

SUPPLEMENTARY INFORMATION: The 

company listed below applied to be 

registered as an importer of various 

basic classes of controlled substances. 

Information on previously published 

notices is listed in the table below. No 

comments or objections were submitted 

and no requests for hearing were 

submitted for this notice. 

Company FR docket Published 

R & D Systems, Inc. 83 FR 

49580.

October 

2, 2018. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823, 952(a) and 

958(a) and determined that the 

registration of the listed registrant to 

import the applicable basic classes of 

schedule I or II controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated the company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing the company’s physical security 

systems, verifying the company’s 

compliance with state and local laws, 

and reviewing the company’s 

background and history. 

Therefore, pursuant to 21 U.S.C. 

952(a) and 958(a), and in accordance 

with 21 CFR 1301.34, the DEA has 

granted a registration as an importer for 

schedule I or II controlled substances to 

the above listed company. 


khammond on DSK30JT082PROD with NOTICES
Federal Register / Vol. 83, No. 247 / Thursday, December 27, 2018 / Notices 66751 

Dated: December 8, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–28078 Filed 12–26–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Myoderm 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before January 28, 2019. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 28, 2019. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

November 2, 2018, Myoderm, 48 East 

Main Street, Norristown, Pennsylvania 

19401–4915 applied to be registered as 

an importer of the following basic 

classes of controlled substances: 

Controlled 

substance Drug code Schedule 

Amphetamine ........ 1100 II 

Lisdexamfetamine 1205 II 

Methylphenidate ... 1724 II 

Nabilone ................ 7379 II 

Oxycodone ............ 9143 II 

Hydromorphone .... 9150 II 

Hydrocodone ........ 9193 II 

Morphine ............... 9300 II 

Oxymorphone ....... 9652 II 

Fentanyl ................ 9801 II 

The company plans to import the 

listed controlled substances for clinical 

trials, research, and analytical purposes. 

Approval of permit applications will 

occur only when the registrant’s activity 

is consistent with what is authorized 

under to 21 U.S.C.952(a)(2). 

Authorization will not extend to the 

import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: December 8, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–28081 Filed 12–26–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Agilent Technologies 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before January 28, 2019. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 28, 2019. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on August 

13, 2018, Agilent Technologies, 250 

Smith Street, North Kingstown, Rhode 

Island 02852 applied to be registered as 

an importer of the following basic 

classes of controlled substances: 

Controlled substance Drug code Schedule 

Marihuana ................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols ............................................................................................................................................ 7370 I 


khammond on DSK30JT082PROD with NOTICES